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PAR1 activation induces rapid 
changes in glutamate uptake and 
astrocyte morphology
Amanda M. Sweeney1,†,*, Kelsey E. Fleming1,*, John P. McCauley1, Marvin F. Rodriguez1,2,‡, 
Elliot T. Martin1, Alioscka A. Sousa3,#, Richard D. Leapman3 & Annalisa Scimemi1
The G-protein coupled, protease-activated receptor 1 (PAR1) is a membrane protein expressed in 
astrocytes. Fine astrocytic processes are in tight contact with neurons and blood vessels and shape 
excitatory synaptic transmission due to their abundant expression of glutamate transporters. PAR1 is 
proteolytically-activated by bloodstream serine proteases also involved in the formation of blood clots. 
PAR1 activation has been suggested to play a key role in pathological states like thrombosis, hemostasis 
and inflammation. What remains unclear is whether PAR1 activation also regulates glutamate uptake 
in astrocytes and how this shapes excitatory synaptic transmission among neurons. Here we show that, 
in the mouse hippocampus, PAR1 activation induces a rapid structural re-organization of the neuropil 
surrounding glutamatergic synapses, which is associated with faster clearance of synaptically-released 
glutamate from the extracellular space. This effect can be recapitulated using realistic 3D Monte Carlo 
reaction-diffusion simulations, based on axial scanning transmission electron microscopy (STEM) 
tomography reconstructions of excitatory synapses. The faster glutamate clearance induced by PAR1 
activation leads to short- and long-term changes in excitatory synaptic transmission. Together, these 
findings identify PAR1 as an important regulator of glutamatergic signaling in the hippocampus and a 
possible target molecule to limit brain damage during hemorrhagic stroke.
The G-protein coupled receptor PAR1 is a serine protease mostly expressed in brain astrocytes1,2. PAR1 is acti-
vated by bloodstream serine proteases like thrombin, the main effector molecule in the blood coagulation cas-
cade, and plasmin, an enzyme involved in the proteolysis of fibrin blood clots3. Thrombin and plasmin activate 
PAR1 by cleaving its extracellular N-terminal domain, revealing a tethered agonist for PAR14,5. Despite being 
irreversible, PAR1 activation remains effective for a limited time, due to rapid PAR1 internalization and lysoso-
mal degradation6. In vitro, synthetic peptides that mimic the aminoacid sequence of the endogenous tethered 
ligand allow to reversibly and selectively activate PAR1 without affecting other potential targets of thrombin 
and plasmin3. Once activated, PAR1 interacts with proteins of the Gq/11, Gi/o, and G12/13 families, regulating 
signal transduction pathways leading to mobilization of intracellular calcium7–9. Consistent with these findings, 
in mouse hippocampal stratum radiatum, PAR1 activation evokes intracellular calcium rise in astrocytes, not 
neurons10.
Astrocytes are the most abundant non-neuronal cells in the brain. In the hippocampus, a brain region that 
plays a critical role in memory formation and generation of temporal lobe seizures11, fine astrocytic processes 
extend towards excitatory synapses12. They form physical barriers to neurotransmitter diffusion and terminate 
excitatory synaptic transmission by removing the neurotransmitter glutamate from the extracellular space through 
the activity of glutamate transporters13. Glutamate uptake is stoichiometrically coupled with the movement of 
Na+, H+ and K+ across the membrane, along the direction determined by their electrochemical gradient14–17. 
In acute brain slices, this stoichiometric and synaptically-activated transporter current (STC) can be 
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Figure 1. PAR1 activation speeds transporter currents and glutamate clearance from astrocytes. 
(A) In-cell comparison of the amplitude of the sustained K+-current in control (10.6 ± 1.2 pA) and TFLLR 
(30 μ M; 10.9 ± 1.3 pA (n = 7), p = 0.64). TFLLR does not change the amplitude of the K+ -current. (B) In-cell 
comparison of astrocyte capacitance in control (7.7 ± 2.0 pF) and TFLLR (8.8 ± 0.9 pF (n = 7), p = 0.62). TFLLR 
does not change the astrocyte capacitance. (C) fSTCs in control (gray) and TFLLR (light blue). Averages of 20 
consecutive fSTCs. Thick lines represent multi-exponential fits of the fSTCs before (black) and after TFLLR 
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monitored using whole-cell patch-clamp recordings from astrocytes18. The time course of the STC provides a 
temporally-distorted view of the lifetime of glutamate at astrocytic membranes18–20. Its time course depends on 
the spatial organization of astrocytic processes and synapses and on the density of expression of glutamate trans-
porters (i.e. the astrocyte uptake capacity). Accordingly, STCs become faster during development, when the glu-
tamate uptake capacity increases through developmental regulation of glutamate transporter expression13. The 
brain neuropil undergoes constant remodeling in physiological21 and pathological conditions22 and these phe-
nomena can shape excitatory transmission in the brain. Whether PAR1 activation is involved in this remodeling 
is not known.
Here we show that, in area CA1 of the mouse hippocampus, PAR1 activation induces rapid and complex 
re-organization of the local neuropil surrounding excitatory synapses, which is associated with faster glutamate 
clearance, reduced glutamate receptor activation and impaired long-term potentiation (LTP). Together, these 
findings identify PAR1 as a powerful regulator of excitatory synaptic function in the brain and a potential molec-
ular target to limit brain damage during pathological conditions associated with damage of the brain vasculature 
like traumatic brain injury, epilepsy and hemorrhagic stroke.
Results
PAR1 activation speeds clearance of synaptically-released glutamate from the hippocampal 
neuropil. To test whether PAR1 regulates the lifetime of synaptically-released glutamate at astrocyte mem-
branes, we performed whole-cell patch-clamp recordings from hippocampal astrocytes in CA1 stratum radiatum, 
in response to Schaffer collateral stimulation. The recorded current consisted of a large, fast-rising inward compo-
nent decaying in tens of milliseconds (i.e. the STC), and a slow-rising, sustained inward component decaying with 
a much slower time course of several seconds18 (Supp. Fig. 1A). The slow current is a sustained K+-current, which 
follows the time course of K+ re-equilibration in the extracellular space18. In a series of control experiments we 
confirmed that: (1) STCs are mediated by glutamate transporters because they are blocked by the broad-spectrum, 
non-substrate, competitive glutamate transporter antagonist TBOA (50 μ M)18,20 (Supp. Fig. 1A); (2) the sustained 
and TBOA-insensitive K+-current was only partially blocked by BaCl2 (200 μ M), a broad-spectrum blocker of Kir 
channels abundantly expressed in glial cells of the retina23, olfactory bulb24 and somato-sensory cortex25 (normal-
ized Ik amplitude in TBOA + BaCl2 versus TBOA: 0.52 ± 0.11 (n = 7), **p = 5.4e-3; data not shown). This effect 
might be due to the presence of Ba2+-insensitive K+ channels in hippocampal astrocytes26. We did not use BaCl2 
in the rest of the experiments not only because it did not block the sustained K+ current, but also because it could 
change the dynamics of synaptic transmission by permeating through voltage-gated Ca2+-channels (substitut-
ing for Ca2+, though much less effectively, in triggering neurotransmitter release27). The kinetics of the STC are 
indistinguishable from those of the facilitated portion of STCs (i.e. the fSTC), isolated by interleaving single and 
paired stimuli to Schaffer collaterals20,28,29 (amp STCTBOA sub 51.6 ± 16.8 pA, fSTC 54.3 ± 15.8 pA p = 0.54; 20–80% 
rise STCTBOA sub 2.2 ± 0.4 ms, fSTC 1.8 ± 0.2 ms p = 0.36; τ fast STCTBOA sub 5.5 ± 0.7 ms, fSTC 5.9 ± 0.7 ms p = 0.70; 
τ slow STCTBOA sub 12.8 ± 0.7 ms, fSTC 11.2 ± 2.6 ms p = 0.57; < t> TBOA sub 10.0 ± 1.9 ms, fSTC 9.4 ± 1.3 ms (n = 4) 
p = 0.84; Supp. Fig. 1B–F). Therefore, TBOA-subtracted STCs or fSTCs can be used interchangeably to estimate 
glutamate clearance. The amplitude and kinetics of fSTCs remain stable over a period of 30–40 min, the typical 
duration of our astrocyte whole-cell patch-clamp recordings (amp fSTCCtrl 49.0 ± 16.8 pA, fSTCtime 46.2 ± 15.6 
pA p = 0.26; 20–80% rise fSTCCtrl 1.6 ± 0.1 ms, fSTCtime 1.8 ± 0.2 ms p = 0.09; τ fast fSTCCtrl 5.7 ± 0.7 ms, fSTCtime 
5.0 ± 0.4 ms p = 0.42; τ slow fSTCCtrl 12.1 ± 2.3 ms, fSTCtime 15.0 ± 4.3 ms p = 0.32; < t> fSTCCtrl 8.3 ± 1.2 ms, 
fSTCtime 9.0 ± 1.1 ms (n = 4) p = 0.14; Supp. Fig. 1G–I). Their kinetics are not altered by the mGluRI antago-
nists LY367385 (50 μ M) and MPEP (10 μ M; 20–80% rise fSTCCtrl 1.8 ± 0.3 ms, fSTCmGluRI 2.5 ± 0.5 ms p = 0.07; 
τ fast fSTCCtrl 5.2 ± 0.9 ms, fSTCmGluRI 5.4 ± 1.4 ms p = 0.88; τ slow fSTCCtrl 12.7 ± 2.7 ms, fSTCmGluRI 12.0 ± 1.7 ms 
p = 0.82 (n = 9)), in agreement with recent work indicating that mGluRI do not affect the glutamate transport 
process30 (Supp. Fig. 2). Therefore, we analyzed fSTCs recorded in the absence of BaCl2 and mGluRI antagonists 
to derive information on glutamate clearance.
TFLLR is a synthetic 5-aa peptide with an aminoacid sequence that mimics the sequence of the tethered 
ligand of PAR14–6,10,31 (Fig. 1). TFLLR (30 μ M), applied for 30 min, did not change the amplitude of the sustained 
(blue). (D) Summary graph: TFLLR does not change the fSTC amplitude (Ctrl: 27.7 ± 4.9 pA; TFLLR: 25.0 ± 4.4 
pA (n = 12), p = 0.40). (E) Summary graph: TFLLR speeds the fSTC slow decay (τ slow; Ctrl: fSTC 20–80% rise 
2.3 ± 0.3 ms, τ fast 5.3 ± 0.9 ms, τ slow 18.3 ± 4.3 ms, < t> 12.1 ± 1.4 ms; TFLLR: fSTC 20–80% rise 2.3 ± 0.2 ms 
p = 0.62, τ fast 5.3 ± 1.0 ms p = 0.94, τ slow 12.0 ± 2.3 ms *p = 0.04, < t> 9.7 ± 1.4 ms (n = 12) *p = 0.04). (F) fSTCs 
in control (black) and TBOA (10 μ M; gray). Average of 20 consecutive fSTCs. Insets: peak-normalized fSTCs. 
(G) As in (F), in TFLLR. (H) Summary graph: TBOA (10 μ M) reduces the fSTC amplitude similarly in control 
(0.36 ± 0.07 (n = 10) ***p = 2.7e-6) and TFLLR (0.36 ± 0.06 (n = 10) ***p = 1.5e-6; Ctrl vs TFLLR p = 0.92). (I) 
Summary graph: TBOA prolongs the fSTC rise and slow decay in control (fSTC Norm 20–80% rise 1.4 ± 0.1 
*p = 0.02, Norm τ fast 1.4 ± 0.5 p = 0.43, Norm τ slow 2.2 ± 0.6 *p = 0.04, Norm < t > 3.1 ± 0.8 (n = 10) *p = 0.03) 
and TFLLR (fSTC Norm 20–80% rise 1.9 ± 0.4 *p = 0.04, Norm τ fast 1.9 ± 0.6 p = 0.18, Norm τ slow 2.9 ± 0.5 
**p = 0.005, Norm < t> 2.6 ± 0.4 (n = 10) **p = 0.006). The effects of TBOA are similar in both conditions 
(Norm 20–80% rise p = 0.23, Norm τ fast p = 0.56, Norm τ slow p = 0.39, Norm < t> p = 0.56). (J) Derived 
clearance of synaptically-released glutamate in control (black) and TFLLR (blue). (K) The clearance centroid is 
faster than the fSTC centroid, in control (< t> fSTC 23.3 ± 2.0 ms, < t> clearance 16.5 ± 2.2 ms (n = 13) **p = 0.002) 
and TFLLR (< t> fSTC 20.6 ± 1.8 ms, < t> clearance 10.1 ± 1.2 ms (n = 12) ***p = 6.7e-4). (L) Summary graph: the 
centroid of glutamate clearance derived from fSTCs is faster in control (16.5 ± 2.2 ms (n = 13)) than TFLLR 
(10.1 ± 1.2 ms (n = 12) *p = 0.02).
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Figure 2. PAR1 activation speeds glutamate clearance without altering the total uptake capacity and diffusion 
properties of the neuropil. (A) Top: scheme of the experimental design. Electrical stimuli evoke glutamate 
release from Schaffer collaterals. Whole-cell patch-clamp recordings from astrocytes in CA1 stratum radiatum 
were used to record transporter currents. Bottom: Time course of synaptically-released glutamate clearance in 
control (black) and TFLLR (blue). Thick lines and shaded areas represent mean ± S.E.M. (B) Top: schematic of 
the experimental design. MNI-L-glutamate (100 μ M) was uncaged over the entire field of view to evoke FTCs in 
astrocytes. Bottom: Time course of glutamate clearance derived from FTCs, in control (black) and in TFLLR (blue). 
Thick lines and shaded areas represent mean ± S.E.M. fSTCs in (A) and FTCs in (B) were obtained from the same 
astrocytes. (C) Summary graph: clearance of synaptically-released glutamate is faster in TFLLR (fSTC < t> clearance 
Ctrl 15.4 ± 1.8 ms (n = 9), TFLLR 10.0 ± 1.3 ms (n = 9) *p = 0.03). Clearance of MNI-L-glutamate is similar in 
control conditions and in TFLLR, suggesting that PAR1 activation does not alter the astrocytic glutamate uptake 
capacity (FTC < t> clearance Ctrl 10.7 ± 2.8 ms (n = 9), TFLLR 8.7 ± 1.2 ms (n = 9) p = 0.50). (D) Left: kymographs 
showing the diffusion profile of AF350 and AF594, pressure applied in free solution (left), in control slices (middle) 
and in slices treated with TFLLR (right). Averages of 10 consecutive applications. Right: Gaussian intensity 
profiles measured 0.7, 2.6, 4.9, and 7.2 s after the pressure application. (E) Summary graph: diffusion coefficients 
of AF350 and AF594 in free solution (Dfree AF350 0.51 ± 0.03 μ m2/ms (n = 6), Dfree AF594 0.49 ± 0.05 μ m2/ms (n = 6)) 
and in slices in control (D*AF350 0.38 ± 0.05 μ m2/ms (n = 6), D*AF594 0.17 ± 0.05 μ m2/ms (n = 6)) and TFLLR 
(D*AF350 0.44 ± 0.11 μ m2/ms (n = 6) p = 0.60, D*AF594 0.22 ± 0.07 μ m2/ms (n = 6) p = 0.54). Gray areas highlight 
the molecular weight of glutamate, AF350 and AF594. (F) Summary graph: TFLLR does not alter the hindrance 
tortuosity (Ctrl λAF350 1.2 ± 0.1 (n = 6), λAF594 1.6 ± 0.1 (n = 5)) (TFLLR λAF350 1.0 ± 0.1 (n = 5) p = 0.30, λAF594 
1.5 ± 0.2 (n = 5) p = 0.51) and hydrodynamic diameter of AF350 and AF594 in slices (Ctrl dH AF350 1.3 ± 0.2 (n = 6), 
dH AF594 2.3 ± 0.4 (n = 5)) (TFLLR dH AF350 1.0 ± 0.2 (n = 5) p = 0.36, dH AF594 2.0 ± 0.5 (n = 5) p = 0.56).
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Figure 3. PAR1 activation alters the structure of the neuropil around excitatory synapses. (A) Left: Electron 
micrograph (20,000X) showing a 2D image of the hippocampal neuropil in CA1 stratum radiatum. Color-coded 
contour lines were used to manually trace and reconstruct the structure of the pre-synaptic terminal (green), 
post-synaptic terminal (white), PSD (red) and astrocytic processes (light blue). Right: Snapshot of the volumes 
reconstructed from the contours shown in the left panel. (B) Close-up views of a representative synaptic contact 
reconstructed from control sections (left) and sections treated with TFLLR (right). (C) Left: Logarithmic scatter 
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K+ current (Ctrl 10.6 ± 1.2 pA, TFLLR 10.9 ± 1.3 pA (n = 7) p = 0.64; Fig. 1A), whole-cell capacitance (Ctrl 
7.7 ± 2.0 pF, TFLLR 8.8 ± 0.9 pF (n = 7) p = 0.62; Fig. 1B), fSTC amplitude (Ctrl 27.7 ± 4.9 pA, TFLLR 25.0 ± 4.4 
pA (n = 12) p = 0.40; Fig. 1C,D), 20–80% rise (Ctrl 2.3 ± 0.3 ms, TFLLR 2.3 ± 0.2 ms (n = 12) p = 0.62; Fig. 1E) 
and fast decay (Ctrl 5.3 ± 0.9 ms, TFLLR 5.3 ± 1.0 ms (n = 12) p = 0.94; Fig. 1E). In contrast, TFLLR significantly 
reduced the slow component of the fSTC decay (Ctrl 18.3 ± 4.3 ms, TFLLR 12.0 ± 2.3 ms (n = 12) *p = 0.04), lead-
ing to a change of its centroid (< t> )20,28 (Ctrl 12.1 ± 1.4 ms, TFLLR 9.7 ± 1.4 ms (n = 12) *p = 0.02; Fig. 1E). Such 
a small effect on the fSTC might mask profound changes in glutamate clearance18.
We estimated the time course of glutamate clearance by using a deconvolution analysis of fSTCs20,28. Briefly, 
the waveform of the fSTC can be thought of as a mathematical transformation (i.e. a convolution) of glutamate 
clearance (an event that lasts a few milliseconds) and a distorting function (i.e. the filter). In our experimental 
conditions, the filter behaves as a linear system which is unaffected by changes in glutamate uptake capacity20,28,29. 
To derive the filter using the deconvolution analysis, we need to record fSTCs before and after applying a low, 
sub-saturating concentration of TBOA20,28. The goal of this manipulation is to block a significant fraction – not 
all – transporters, to prolong the time course of the fSTC without completely abolishing it20,28. When the gluta-
mate uptake capacity of astrocytes is low, as it happens with TBOA (10 μ M), the fSTC decay reflects more closely 
the time course of glutamate clearance (not the filter), which can be approximated by an instantaneously-rising 
function decaying with the same time course of the fSTC20,28. Deconvolving the filter derived in TBOA (10 μ M) 
from the fSTC in control (when the uptake capacity is intact) allows deriving the time course of glutamate 
clearance in control conditions. TBOA (10 μ M) induced a similar reduction of the fSTC amplitude in control 
(0.36 ± 0.07 (n = 10), ***p = 2.7e-6) and TFLLR (0.36 ± 0.06 (n = 10), ***p = 1.5e-6; Ctrl vs TFLLR p = 0.92; 
Fig. 1F–H). TBOA (10 μ M) did not affect the fast component of the fSTC decay, but prolonged its rise, slow 
decay and centroid, in control and TFLLR (fSTC Norm 20–80% rise Ctrl 1.4 ± 0.1, TFLLR 1.9 ± 0.4, p = 0.23; 
Norm τ fast Ctrl 1.4 ± 0.5, TFLLR 1.9 ± 0.6, p = 0.56; Norm τ slow Ctrl 2.2 ± 0.6, TFLLR 2.9 ± 0.5, p = 0.39; Norm < 
t> Ctrl 3.1 ± 0.8 (n = 10), TFLLR 2.6 ± 0.4 (n = 10), p = 0.56; Fig. 1I). As expected20,28, the time course of gluta-
mate clearance was significantly faster than the time course of the fSTC in control (< t> fSTC 23.3 ± 2.0 ms, fSTC 
< t> clearance 16.5 ± 2.2 ms (n = 13) **p = 0.002) and TFLLR (< t> fSTC 20.6 ± 1.8 ms, fSTC < t> clearance 10.1 ± 1.2 ms 
(n = 12) ***p = 6.7e-4; Fig. 1J,K). Notably, TFLLR sped the time course of glutamate clearance from astrocytes 
(< t> fSTC Ctrl 16.5 ± 2.2 ms (n = 13), TFLLR 10.1 ± 1.2 ms (n = 12) *p = 0.02; Fig. 1J,L), consistent with the fSTC 
data (Fig. 1C–E). This effect is consistent with PAR1 speeding clearance of synaptically-released glutamate from 
the extracellular space and could be explained by three potential mechanisms: (1) TFLLR increases the sur-
face expression of glutamate transporters; (2) TFLLR changes the diffusion properties of the entire neuropil; (3) 
TFLLR induces local structural rearrangements of astrocytic processes adjacent to Schaffer collateral synapses. 
The following sections aim to test each one of these scenarios.
PAR1 activation does not change the astrocytic glutamate uptake capacity. If TFLLR increased 
glutamate transporter expression in astrocytes, we would expect astrocytes to remove flash-uncaged glutamate 
from the extracellular space faster in TFLLR20,29. This is because when uncaging glutamate, all transporters 
are activated simultaneously by the same agonist concentration, regardless of their sub-cellular location and 
proximity to active synapses. To compare fSTCs and flash-uncaging transporter currents (FTCs) in the same 
astrocytes, we interleaved synaptic stimulations with UV flashes to uncage a sub-saturating concentration of 
MNI-L-glutamate in stratum radiatum (100 μ M; Fig. 2A–C). Consistent with experiments in Fig. 1J,L, clearance 
of synaptically-released glutamate was faster in TFLLR (< t> fSTC Ctrl 15.4 ± 1.8 ms (n = 9), TFLLR 10.0 ± 1.3 ms 
(n = 9) *p = 0.03; Fig. 2A,C). In contrast, clearance of flash-uncaged glutamate was similar in control and TFLLR 
(< t> FTC Ctrl 10.7 ± 2.8 ms (n = 9), TFLLR 8.7 ± 1.2 ms (n = 9) p = 0.50; Fig. 2B,C). These findings indicate 
that PAR1 does not alter the total glutamate uptake capacity of astrocytes and their total glutamate transporter 
expression.
PAR1 activation does not change the diffusion properties of the entire hippocampal neuropil. 
Widespread changes in the diffusion properties of the entire neuropil can be detected by monitoring the decay 
of the fluorescence signal emitted by pressure-applied, cell-impermeant dyes (Alexa Fluor 350 (AF350), Alexa 
Fluor 594 (AF594)) with different excitation/emission spectra and molecular weight similar to glutamate 
plot of the volume of the post- and pre-synaptic terminals of each synapse reconstructed from control (white 
(n = 12)) and TFLLR-treated slices (light blue (n = 13)). Right: Logarithmic scatter plot of the PSD area plotted 
against the volume of the pre-synaptic terminal of each synapse reconstructed from control (white) and TFLLR-
treated slices (light blue). The size of the pre- and post-synaptic terminal increases progressively as the area of 
the PSD increases, suggesting that each one of these parameters correlates with the size of the entire synaptic 
contact. (D) Left: The volume of the peri-synaptic astrocytic processes increases progressively with their surface 
area. Right: lack of correlation between the surface area of astrocytic processes and the PSD area. This finding 
suggests that under our experimental conditions the astrocytic coverage is similar across synaptic contacts 
of different dimensions. (E) Left: the average astrocyte-PSD distance and the mean astrocyte surface area at 
synapses reconstructed from sections of control slices (black; astrocyte-PSD distance 116.5 ± 16.7 nm, mean 
astrocyte surface area 0.92 ± 0.13 μ m2 (n = 11)) change in TFLLR (blue; astrocyte-PSD distance 190.9 ± 20.7 nm 
(n = 13) *p = 0.01, mean astrocyte surface area 0.58 ± 0.04 μ m2 (n = 13) *p = 0.03). Right: the average number 
of astrocytic processes surrounding synapses increases in TFLLR (number of astrocytic processes Ctrl 2.2 ± 0.4, 
PSD area 0.10 ± 0.03 μ m2 (n = 12)) (number of astrocytic processes TFLLR 4.2 ± 0.7 *p = 0.02, PSD area 
0.08 ± 0.02 μ m2 (n = 13) p = 0.64).
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(MWAF350 = 349 Da, MWAF594 = 759, MWGlut = 147 Da; Fig. 2D–F). We used two-photon laser scanning micros-
copy (2P-LSM) and line scans to monitor with high temporal resolution the fluorescent intensity profile of AF350 
and AF59432,33, through which we estimated their diffusion coefficient in free solution (Dfree) and in stratum radia-
tum (D*). AF350 and AF594 diffused similarly in control and TFLLR (D*AF350 Ctrl 0.38 ± 0.05 μ m2/ms (n = 6), 
TFLLR 0.44 ± 0.11 μ m2/ms (n = 6) p = 0.60; D*AF594 Ctrl 0.17 ± 0.05 μ m2/ms (n = 6), TFLLR 0.22 ± 0.07 μ m2/ms 
(n = 6) p = 0.54; Fig. 2D,E). The hindrance to diffusion experienced by the two fluorophores (i.e. the tortuos-
ity, λ) and their effective diameter in aqueous solution (i.e. the hydrodynamic diameter, dH) were also similar 
in control (λAF350 1.2 ± 0.1 (n = 6), λAF594 1.6 ± 0.1 (n = 5), dH AF350 1.3 ± 0.2 (n = 6), dH AF594 2.3 ± 0.4 (n = 5)) 
and TFLLR (λAF350 1.0 ± 0.1 (n = 5) p = 0.30; λAF594 1.5 ± 0.2 (n = 5) p = 0.51; dH AF350 1.0 ± 0.2 (n = 5) p = 0.36; 
dH AF594 2.0 ± 0.5 (n = 5) p = 0.56; Fig. 2F). These findings indicate that PAR1 activation does not alter the diffu-
sion properties of small molecules through large regions of the hippocampal neuropil that extend for 50–100 μ m, 
significantly larger than individual Schaffer collateral synapses34. Despite its high temporal resolution, the spatial 
resolution of 2P-LSM in comparison to the size of the extracellular space and may not detect subtle effects on dif-
fusion that occur at the nanometer scale. Therefore, the 2P-LSM diffusion analysis cannot rule out that local and 
more subtle effects of PAR1 might occur in the immediate vicinity of excitatory synapses.
PAR1 activation induces local changes in the structure of the neuropil. We used axial STEM 
tomography to obtain higher resolution information on the structure of the neuropil on thick sections (∼ 1 μ m) 
of stratum radiatum from acute hippocampal slices prepared using the same procedures used for the electrophys-
iology experiments. We analyzed samples from control slices and from slices treated with TFLLR (30 μ M) for 
30 min (as in the electrophysiology experiments). We manually traced the pre-synaptic terminal, post-synaptic 
density (PSD), spine head and astrocytic processes around excitatory synapses in the axial STEM tomography 
data (Fig. 3A,B; Table 1). In agreement with previous findings, the volume of the reconstructed excitatory syn-
apses varied widely across synapses34 (Fig. 3C, Left). The volume of pre- and post-synaptic terminals was highly 
correlated with each other, in control and TFLLR (r = 0.86; Fig. 3C, Left). The PSD area was also highly correlated 
with the volume of pre-synaptic terminals (r = 0.94; Fig. 3C, Right), suggesting that any of these parameters can 
serve as proxy measures for the size of the entire synapse. We confirmed that the volume and surface area of the 
astrocytes were proportional and correlated to one another (r = 0.93; Fig. 3D, Left). The astrocyte surface area to 
volume ratio differed across synapses of different sizes (Fig. 3D, Left). Because preserving the surface area to vol-
ume ratio as size increases requires changing to more complex shapes, these findings suggest that the overall shape 
of astrocytic processes does not change depending on their size. We did not detect any correlation between the 
surface area of astrocytic processes and the surface area of the PSD (Fig. 3D, Right) or between the size of a syn-
apse and the distance of neighboring astrocytic processes (data not shown). Because at Schaffer collateral synapses 
the size of the PSD and of the active zone scales with release probability34,35, this finding suggests that the extent of 
astrocytic coverage, in our experimental conditions, is not proportional to synapse release probability. All these 
general structural features remained unaltered in TFLLR (Fig. 3A–D). Surprisingly, TFLLR caused an increase 
in the nearest distance between the PSD and neighboring astrocytic processes (Ctrl 116.5 ± 16.7 nm (n = 11), 
TFLLR 190.9 ± 20.7 nm (n = 13) *p = 0.010; Fig. 3E, Left) and a reduction in the astrocyte mean surface area 
(Ctrl 0.92 ± 0.13 μ m2 (n = 11), TFLLR 0.58 ± 0.04 μ m2 (n = 13) *p = 0.029; Fig. 3E, Left). These findings are not in 
conflict with the lack of effect of TFLLR on cell capacitance which, at its best, provides information on the capac-
itance and surface area of entire cells, not of their finest processes (Fig. 1B). They are surprising however, because 
by allowing astrocytic processes to move away from excitatory synapses and shrink, PAR1 should prolong – not 
speed – glutamate clearance (Fig. 1J,L). One important additional effect of TFLLR is that it causes proliferation of 
astrocytic processes, increasing their number around excitatory synapses (Ctrl 2.2 ± 0.4 (n = 12), TFLLR 4.2 ± 0.7 
(n = 13) *p = 0.022) without altering the PSD area (Ctrl 0.099 ± 0.03 μ m2 (n = 12), TFLLR 0.08 ± 0.02 μ m2  
(n = 13) p = 0.64; Fig. 3E, Right). On its own, this effect would increase the local glutamate uptake capacity of 
astrocytes and speed glutamate clearance. Together, these data shows that PAR1 induces rapid and complex 
changes in the local structure of the neuropil around excitatory synapses. It is difficult, however, to predict 
whether all these effects should speed or slow down glutamate clearance.
Ctrl TFLLR
PSD surface area 0.10 ± 0.11 μ m2 (n = 12) 0.08 ± 0.05 μ m2 (n =  13)
Pre-synaptic volume 0.08 ± 0.08 μ m3 (n = 12) 0.06 ± 0.03 μ m3 (n =  13)
Post-synaptic volume 0.04 ± 0.04 μ m3 (n = 12) 0.03 ±  0.02 μ m3 (n =  13)
Mean astrocytic process volume 0.03 ± 0.02 μ m3 (n = 27) 0.02 ±  0.01 μ m3 (n =  55) *p =  0.025
Mean astrocytic process SA 0.80 ± 0.45 μ m2 (n = 27) 0.57 ±  0.22 μ m2 (n =  55) *p =  0.039
Mean number of astrocytic processes at each synapse 2.25 ± 1.54 (n = 12) 4.23 ±  2.38 (n = 13)
Mean PSD-astrocytic process distance at each synapse 116.5 ± 55.4 nm (n = 12) 190.9 ± 74.6 nm (n =  13)
Mean astrocytic process volume of each synapse 0.03 ± 0.02 μ m3 (n = 11) 0.02 ± 0.01 μ m3 (n = 13) *p = 0.031
Mean astrocytic process SA at each synapse 0.91 ± 0.43 μ m2 (n = 11) 0.58 ± 0.15 μ m2 (n = 13) *p = 0.029
Total astrocytic process volume at each synapse 0.06 ± 0.03 μ m3 (n = 12) 0.07 ± 0.05 μ m3 (n = 13)
Total astrocytic process SA at each synapse 1.79 ± 1.07 μ m2 (n = 12) 2.52 ± 1.63 μ m2 (n = 13)
Table 1.  Geometrical properties of excitatory synapses reconstructed with axial STEM tomography.
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Figure 4. Local changes in astrocytic coverage of excitatory synapses speed the lifetime of synaptically-
released glutamate in the extracellular space (simplified geometries). (A,B) Snapshots of the geometries 
used to run 3D Monte Carlo reaction-diffusion simulations in control (A) and TFLLR (B), taken 50 μ s after 
the release of 2,000 glutamate molecules from the center of the synaptic cleft. The size of the pre- (green) and 
post-synaptic terminal (white), the number and surface area of neighboring astrocytic processes (light blue) 
and their distance from the PSD match the average values from the axial STEM tomography reconstructions 
(Fig. 3, Table 1 and 2). Glutamate transporters are represented as icosahedrons (blue; 10,800/μ m2)13; glutamate 
molecules are represented as tori, diffusing inside (yellow) and outside the synaptic cleft (orange). (C) Left: 
www.nature.com/scientificreports/
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In silico models recapitulate the effect of PAR1 activation on glutamate clearance. As men-
tioned in the previous section, local changes in the number and surface area of astrocytic processes could increase 
the local uptake capacity of the neuropil at excitatory synapses. A rough estimate of the local uptake capacity can 
be obtained by multiplying the mean surface density of glutamate transporters (d = 10,800 μ m−2)13 by the surface 
area of one astrocytic process (SA1astro) and the number of astrocytic processes at each synapse (Nastro). In our 
experiments, this leads to a ∼ 40% increase in the local uptake capacity of the neuropil in TFLLR. To determine 
how these effects could act in concert with changes in the distance between astrocytes and synapses, we generated 
3D Monte Carlo reaction-diffusion simulations of glutamate diffusion in the hippocampal neuropil. We first used 
simplified geometries, where the volume and surface area of neuronal and astrocytic structures matched those 
obtained from the reconstructions (Fig. 4A,B, Table 2). We confirmed that these simulations are sensitive to 
changes in glutamate uptake capacity, because the lifetime of glutamate in the neuropil is prolonged when reduc-
ing the surface density of glutamate transporters (Fig. 4C–H). In these simulations, the extracellular glutamate 
concentration decays faster in TFLLR than in control, in the cleft (Fig. 4C Left,D) and the neuropil (Fig. 4E Left,F), 
even when the uptake capacity is low (Fig. 4C Right,D,E Right,F). This effect is associated with an increased rate 
of glutamate binding, unbinding and translocation by astrocytic transporters in TFLLR (Fig. 4G,H). These results 
are consistent with our experimental findings (Fig. 1H,I). To rule out any bias due to the use of simplified geom-
etries, we performed analogous simulations using geometries from the axial STEM tomography reconstructions 
(Fig. 5; Table 3). Here the PSD-astrocytes distance, number of astrocytic processes and astrocyte surface area 
closely matched the mean values measured across synapses in control and TFLLR (Fig. 3E). The simulations 
provided similar results to those in Fig. 4, showing that TFLLR speeds the lifetime of glutamate in the cleft and 
the neuropil (Fig. 5). The effects of TFLLR were more pronounced when using reconstructed synapses, likely 
because the synaptic cleft is less confined than in simplified geometries. The results of these simulations support 
the hypothesis that PAR1, by modifying the 3D organization of astrocytic processes at excitatory synapses, speeds 
clearance of synaptically-released glutamate.
PAR1 activation reduces GluA receptor activation in CA1 pyramidal cells. If PAR1 activation 
speeds glutamate clearance from astrocytes, we would expect it to also change glutamatergic signaling among 
neurons mediated by GluA/N receptors. Accordingly, TFLLR (30 μ M) induced a consistent decrease in the 
GluA-EPSC amplitude in CA1 pyramidal cells voltage-clamped at − 70 mV (0.79 ± 0.07 (n = 21) **p = 8.0e-3; 
Fig. 6A). This effect was not associated with changes in the paired-pulse ratio (PPR, 1.08 ± 0.06 (n = 9) p = 0.26; 
Fig. 6B), ruling out pre-synaptic effects of PAR136,37. To rule out any confounding effect due to GluA recep-
tor desensitization, we repeated these experiments in cyclothiazide (100 μ M)38–41 (Fig. 6C,D). In cyclothiazide, 
TFLLR reduced the GluA-EPSC amplitude (0.78 ± 0.08 (n = 7) *p = 0.03), not PPR (1.10 ± 0.02 (n = 7) p = 0.17). 
Therefore, PAR1 reduces GluA receptor activation without altering pre-synaptic function.
If PAR1 sped glutamate clearance, we would also expect it to increase the sensitivity of GluA receptors to the 
competitive, low-affinity antagonist kynurenate, because its ability to rapidly bind and unbind from GluA recep-
tors varies with the amplitude and decay of the glutamate concentration profile detected by GluA receptors19,29,42–44. 
To test this hypothesis, we recorded GluA-EPSCs in control and kynurenate (300 μ M). We then washed out 
kynurenate, applied TFLLR, repeated the kynurenate application in TFLLR and then washed out kynurenate 
(Fig. 6E). Kynurenate reduced the GluA-EPSC amplitude to 0.29 ± 0.06 in control (***p = 3.8e-3; Fig. 6E–G) 
and 0.19 ± 0.02 in TFLLR ((n = 7) ***p = 4.1e-4; Ctrl vs TFLLR *p = 0.02). The effects of kynurenate in con-
trol and TFLLR were highly correlated (r = 0.98; Fig. 6G), suggesting that synapses activated by smaller gluta-
mate transients (not necessarily smaller synapses) are also more susceptible to changes in astrocytic coverage 
induced by TFLLR. Kinetic models of GluA receptors confirmed that the more pronounced effect of kynurenate 
on GluA-EPSCs in TFLLR is consistent with PAR1 activation reducing the amplitude and/or duration of the glu-
tamate concentration profile at GluA receptors (Fig. 6H,I).
The ability of TFLLR to reduce GluA receptor activation could shape the response of excitatory synapses to 
repetitive stimuli, as indicated by kinetic models in which reducing the peak/decay of the glutamate concentra-
tion profile increases summation of consecutive GluA-EPSCs (Fig. 6J). Cells in which GluA-EPSCs were more 
powerfully blocked by TFLLR showed increased summation of consecutive EPSCs (Fig. 6K,M). Together, these 
results suggest that the subtle structural changes in the local environment around excitatory synapses induced by 
PAR1 can significantly change the dynamics of excitatory synaptic transmission at Schaffer collateral synapses.
PAR1 activation reduces phasic GluN receptor activation in CA1 pyramidal cells. The slow glu-
tamate unbinding and desensitization rates of GluN receptors make them well-suited to detect PAR1-induced 
changes in phasic and tonic glutamatergic transmission45,46. TFLLR reduced the amplitude, rise and decay of 
Time course of glutamate diffusion in the synaptic cleft in control (black) and TFLLR (blue). Right: As in the left 
panel, with reduced surface density of glutamate transporters (5,400/μ m2). (D) Summary graph: TFLLR speeds 
the glutamate concentration profile in the cleft, at different glutamate transporter densities. (E) Time course 
of glutamate diffusion in the extra-synaptic neuropil, with an astrocytic glutamate transporter surface density 
of 10,800 μ m−2 (left) and 5,400/μ m2 (right). (F) Summary graph: The lifetime of glutamate in the neuropil is 
faster in TFLLR than in control conditions, at different glutamate transporter densities. (G) Cumulative plots 
of binding (solid curves), unbinding (dotted curves) and translocation reactions (dashed curves) measured in 
control (black) and TFLLR (blue), with 10,800/μ m2 (left) and 5,400/μ m2 glutamate transporters (right). (H) Simplified 
Markov model of glutamate transporters used in the 3D Monte Carlo reaction-diffusion simulations (rate constants 
for each reaction are reported in the Methods).
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GluN-EPSCs (amp 0.29 ± 0.02 ***p = 1.1e-8, 20–80% rise 0.71 ± 0.11 *p = 0.04, t50 0.61 ± 0.09 (n = 8) **p = 4.0e-3; 
Fig. 7A,C,E). These effects were not accounted by rundown of GluN-EPSCs, which we monitored by recording 
GluN-EPSCs for ∼ 30 min without TFLLR (Fig. 7B,D,F). In these time-dependent control experiments, there 
was a small reduction of the GluN-EPSC amplitude, with no change in its rise and decay (amp 0.70 ± 0.08, 
***p = 0.003; 20–80% rise 1.14 ± 0.08, p = 0.10; t50 0.971 ± 0.08 (n = 12) p = 0.69). However, the effects of TFLLR 
on GluN-EPSCs were significantly different from the ones measured in time-dependent control experiments 
(amp ***p = 2.4e-4; 20–80% rise **p = 7.3e-3; t50 *p = 0.01).
If these effects were due to faster glutamate clearance (Fig. 1J), we would expect D-AA, a competitive 
low-affinity GluN receptor antagonist, to reduce the GluN-EPSC amplitude more in TFLLR than in control. 
Accordingly, D-AA (100 μ M) reduced the GluN-EPSC amplitude to 0.42 ± 0.05 in control ((n = 11) ***p = 4.5e-7) 
and 0.25 ± 0.04 in TFLLR ((n = 14) ***p = 2.8e-11; Ctrl vs TFLLR *p = 0.014). In contrast, the competitive 
high-affinity antagonist APV reduced the GluN-EPSC amplitude similarly in control (0.30 ± 0.04 ***p = 9.4e-7) 
and TFLLR (0.36 ± 0.05 ***p = 2.7e-4; Ctrl vs TFLLR p = 0.43; Fig. 7G,H). The different effect of D-AA in control 
and TFLLR, not detected with APV, suggests that PAR1 activation reduces GluN-receptor activation by altering 
the glutamate concentration profile at GluN receptors.
Does TFLLR also change the steady-state concentration of glutamate in the extracellular space? A tonic 
GluN-mediated current can be measured by voltage-clamping CA1 pyramidal cells at + 40 mV, before and after 
blocking GluN receptors with a saturating concentration of APV (50 μ M)47. For comparison across cells with dif-
ferent surface area, we divided the APV-sensitive tonic current by the cell capacitance48. The GluN tonic current 
density was similar in control (0.20 ± 0.08 pA/pF (n = 6)) and TFLLR (0.28 ± 0.09 pA/pF (n = 8) p = 0.53; Fig. 7J). 
These findings are consistent with the hypothesis that PAR1 activation controls phasic synaptic transmission 
without altering the steady-state ambient glutamate concentration.
PAR1 activation impairs long-term potentiation. GluA/N receptors play a crucial role in shaping 
long-term plasticity at Shaffer collateral synapses49. LTP induction requires a rise in post-synaptic calcium con-
centration through GluN receptors, whereas LTP expression requires trafficking of GluA receptors to the cell 
membrane49. We performed extracellular field recordings from CA1 stratum radiatum and used a high-frequency 
stimulation (HFS: 100 Hz, 1 s) as the LTP-induction protocol. HSF induced LTP in control conditions (Norm 
fEPSC slope 1.31 ± 0.13 (n = 9) *p = 0.04; Fig. 8A,C) but did not induce LTP in TFLLR (Norm fEPSC slope 
0.96 ± 0.09 (n = 6) p = 0.66; Ctrl vs TFLLR *p = 0.04 Fig. 8B,C). Therefore, by inducing local changes in the local 
structure of the neuropil surrounding excitatory synapses, PAR1 speeds glutamate clearance, limits GluA/N 
receptor activation and impairs LTP expression at Schaffer collateral synapses.
Discussion
Astrocytes play a fundamental role in clearing synaptically-released glutamate from the extracellular space, 
through the activity of glutamate transporters18,42,50. By rapidly binding synaptically-released glutamate, the trans-
porters limit glutamate diffusion away from the synaptic cleft and keep the extracellular glutamate concentration 
at low nanomolar levels, to prevent glutamate-induced excitotoxicity20,29,47,51. Recent findings indicate that the fine 
astrocytic processes adjacent to excitatory synapses are highly dynamic and undergo significant structural reor-
ganization in physiological conditions and during hypotonic stress21,22,52–54. To date, no experimental evidence 
has shown that these structural rearrangements can be regulated by activation of membrane serine protease, G 
protein-coupled receptors like PAR1. The results presented here describe a novel form of regulation of astrocytic 
processes around excitatory synapses and of glutamate uptake, both mediated by PAR1 activation. We show that 
the rapid and complex structural reorganization of astrocytic processes induced by PAR1 shape the lifetime of 
synaptically-release glutamate in the extracellular space (Figs 1 and 2), phasic excitatory synaptic transmission 
(Figs 6 and 7) and long-term plasticity (Fig. 8). They do not alter the overall uptake capacity of the entire hip-
pocampal neuropil (Fig. 2), and do not lead to changes in tonic glutamatergic signaling (Fig. 7).
PAR1 is a G-protein coupled receptor known for its role in hemostasis and inflammation6,55. In the cen-
tral nervous system, PAR1 is mostly expressed in astrocytic cell bodies and fine processes closely opposed to 
excitatory synapses and blood brain capillaries1. PAR1 interacts with G proteins of the Gq/11, Gi/o and G12/13 
Ctrl TFLLR
PSD surface area 0.10 μ m2 0.10 μ m2
Pre-synaptic volume 0.07 μ m3 0.06 μ m3
Post-synaptic volume 0.04 μ m3 0.03 μ m3
Mean astrocytic process volume 0.05 μ m3 0.10 μ m3
Mean astrocytic process SA 0.89 μ m2 0.60 μ m2
Number of astrocytic processes 2 4
PSD- Astrocytic process distance 116 nm 190 nm
Total astrocytic process volume at each 
synapse 0.10 μ m
3 0.10 μ m3
Total astrocytic process SA at each synapse 1.78 μ m2 2.40 μ m2
Table 2.  Geometrical properties of excitatory synapses used for 3D Monte Carlo reaction-diffusion 
simulations (Fig. 4).
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Figure 5. Local changes in astrocytic coverage of excitatory synapses speed the lifetime of synaptically-
released glutamate in the extracellular space (reconstructed geometries). (A) Close-up view of glutamate 
molecules (orange) diffusing away from the synaptic cleft in a 3D reconstruction from axial STEM tomography 
of an excitatory synapse in control (left) and TFLLR (right). The snapshots are taken 50 μ s after glutamate release 
from the center of the synaptic cleft. Color codes: pre-synaptic terminal (green), post-synaptic terminal (white), 
PSD (red), astrocytic processes (light blue), glutamate transporters (blue icosahedrons), extra-synaptic glutamate 
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subfamilies, which bind to distinct cytoplasmic domains of the receptor7. Our findings indicate that PAR1 activa-
tion does not change the total uptake capacity of astrocytes and the diffusion properties of the entire hippocampal 
neuropil (Fig. 2). Instead, PAR1 activation has profound local effects and changes the fine structure and arrange-
ment of astrocytic processes around excitatory synapses, which include reduced surface area, increased distance 
from the synapse and proliferation of astrocytic processes (Fig. 3). These findings are consistent with previous 
work suggesting the existence of a PAR1-dependent control of astrocytic processes proliferation, based on GFAP 
immuno-labeling experiments56. This work, however, did not clarify whether this effect was associated with func-
tional changes in glutamate clearance56. Our findings are consistent with a growing number of reports suggesting 
that the precise location of astrocytic processes with respect to excitatory synapses powerfully controls the rate 
of glutamate uptake50,53,54,57,58. They show that these changes can occur rapidly, within 30 min following PAR1 
activation. The reason for such a local effect of PAR1 is not known, but may depend on the sub-cellular distri-
bution of target molecules. Accordingly, the fact that astrocytic processes express high levels of target glutamate 
transporters59 may render them more susceptible to PAR1 activation.
Our findings do not support other studies suggesting that PAR1 activation triggers glutamate release from 
astrocytes in the nucleus of the solitary tract, hippocampus and in culture through mechanisms that might involve 
activation of astrocytic Bestrophin-1 anion channels60–62. Not only, we find that PAR1 speeds glutamate clearance, 
but it also reduces GluA/N activation in CA1 pyramidal neurons (Figs 6 and 7). In addition, kynurenate and 
D-AA (competitive, low-affinity antagonists for GluA and GluN receptors, respectively), which competes with 
glutamate for binding to their target receptors, reduces the GluA/N EPSC amplitude more effectively in TFLLR 
than in control conditions, a result that is not consistent with PAR1 activation triggering glutamate release from 
astrocytes. Our results indicate that the effects of PAR1 influence the glutamate lifetime in and out of the syn-
aptic cleft. The reasons for the discrepancy among studies are not clear, but we cannot rule out the existence of 
brain region-specific regulatory mechanisms underlying different effects of PAR1 activation. Other technical 
aspects, including differences in the age of the animals used for the experiments (8–9 weeks in61 versus 2–3 weeks 
in our experiments), might contribute to a progressively lager role of Bestrophin-1 receptors during postnatal 
development63.
The PAR1-dependent modulation of astrocyte morphology and glutamatergic signaling is significant for 
understanding the function of the brain in pathological conditions. PAR1 is activated by serine proteases in the 
bloodstream (e.g. thrombin and plasmin), which take part in signaling cascades involved in the formation of 
blood clots. Under physiological conditions, the blood brain barrier prevents these proteins from diffusing out of 
the lumen of blood vessels. However, during cerebrovascular damage induced by traumatic brain injury, seizures 
and hemorrhagic stroke, the blood-brain barrier breaks down leading to diffusion of thrombin and plasmin in the 
brain neuropil. By reducing the lifetime of glutamate in the extracellular space and by limiting glutamate receptor 
activation, PAR1 activation induces changes in short-term plasticity at Schaffer collateral synapses, altering their 
response to repetitive stimuli. PAR1 activation also impairs the expression of LTP, a candidate mechanism under-
lying memory formation64,65. In this context, our findings identify PAR1 as an important novel target molecule to 
prevent the onset of cognitive impairment following small hemorrhagic stroke in the brain.
Materials and Methods
Ethics statement. All experimental protocols involving animals were performed in accordance with the 
guidelines of the Institutional Animal Care and Use Committee at SUNY Albany. The experimental protocols and 
methods were approved by the Institutional Animal Care and Use Committee at SUNY Albany (Project #13-011).
Electrophysiology experiments and data analysis. Acute hippocampal slices were obtained from 
C57BL/6 mice of either sex (P11-18), deeply anesthetized with isoflurane and decapitated in accordance with 
SUNY Albany Animal Care and Use Committee guidelines. The brain was rapidly removed and placed in 
ice-cold slicing solution bubbled with 95% O2-5% CO2, containing (in mM): 119 NaCl, 2.5 KCl, 0.5 CaCl2, 1.3 
MgSO4·H2O, 4 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, and 22 glucose; 320 mOsm; pH 7.4. Transverse hippocampal 
slices (250 μ m thick) were prepared using a vibrating blade microtome (VT1200S, Leica Microsystems, Wetzlar, 
Germany). After cutting, slices were stored in this solution in a submersion chamber at 36 °C for 30 min and at 
room temperature for at least 30 min and up to 4 hours. The recording solution contained (in mM): 119 NaCl, 2.5 
KCl, 2.5 CaCl2, 1 MgCl2, 26.2 NaHCO3, 1 NaH2PO4, 22 glucose; 300 mOsm; pH 7.4. Whole-cell patch recordings 
were obtained from CA1 pyramidal neurons and astrocytes identified under infrared-differential interference 
contrast using an upright fixed-stage microscope (BX51 WI, Olympus Corporation, Tokyo, Japan). The internal 
solution used to record GluA-EPSCs in CA1 pyramidal cells contained (in mM): 120 CsCH3SO3, 10 EGTA, 20 
HEPES, 2 MgATP, 0.2 NaGTP, 5 QX-314Br, 5 NaCl; 290 mOsm; pH 7.2. The internal solution used to record 
transporter currents in astrocytes had the same composition except that 120 CsCH3SO3 was replaced with 120 
KCH3SO3. To record transporter currents, the following drugs were added to the recording solution (in μ M): 
picrotoxin (100), CGP52432 (5), 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide 
(orange tori), cleft glutamate (yellow tori). The geometrical parameters of these synapses are included in Table 3. 
(B) Left: Time course of glutamate diffusion in the synaptic cleft, in control (black) and TFLLR (blue). Right: 
Summary graph showing that TFLLR speeds the lifetime of glutamate in the synaptic cleft. (C) Left: Time course 
of glutamate diffusion in the neuropil in control (black) and TFLLR (blue). Right: Summary graph showing 
that TFLLR speeds the lifetime of glutamate in the neuropil. (D) Cumulative plots of binding (solid curves), 
unbinding (dotted curves) and translocation reactions (dashed curves) measured in control (black) and TFLLR 
(blue) simulations.
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(NBQX, 10), (RS)-3-(2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP, 10), (2S)-2-Amino-2-[(1S,2S)-
2-carboxycycloprop-1-yl]-3-(xanth-9-yl) propanoic acid (LY341495, 1), (RS)-α -Methylserine-O-phosphate 
(MSOP, 100) and 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX, 1), to block GABAA, GABAB, GluA, GluN, 
mGluRII-III and adenosine receptors, respectively. CPP or NBQX were omitted from the recording solution 
when recording GluA or GluN-EPSCs, respectively. CPP and NBQX were not used to record field EPSPs (Fig. 8). 
All recordings were obtained under voltage-clamp configuration using a Multiclamp 700B amplifier and a 10 KHz 
low-pass filter (Molecular Devices, Sunnyvale, CA). All traces were digitized at 10 KHz and analyzed off-line with 
custom-made software (A.S.) written in IgorPro 6.36 (Wavemetrics, Lake Oswego, OR). The electrode resistance 
was ∼ 2.5 MΩ. The series resistance was monitored throughout the experiments by applying a − 3 mV pulse, 
100 ms before evoking the synaptic currents. Data were discarded if the series resistance changed more than 20% 
during the course of the experiment. GluA-EPSCs and transporter currents were evoked by delivering constant 
voltage electrical pulses (50 μ s) through bipolar stainless steel electrodes (Cat. MX21AES (JD3); Frederick Haer 
Company, Bowdoin, ME) placed in CA1 stratum radiatum, ∼ 100 μ m away from the recorded cell. Single and 
paired pulses (100 ms inter-pulse interval) were delivered every 10 s. The amplitude of the sustained K+ current 
was measured in a 50 ms time window, positioned 200 ms after the stimulus artifact. To record flash-activated 
transporter currents (FTCs), 4-methoxy-7-nitroindolinyl-caged-L-glutamate (MNI-L-glutamate; 100 μ M) was 
added to the perfusion solution and uncaged using a Flashmic Xe-lamp (Rapp OptoElectronic GmbH, Hamburg, 
Germany) connected to the epi-illumination port29. This concentration of MNI-L-glutamate does not saturate 
glutamate transporters, a necessary requirement to perform the deconvolution analysis and estimate glutamate 
clearance from FTCs and the results are not expected to differ when uncaging different sub-saturating concen-
trations of this compound20. To subtract the stimulation artifact from the FTC, we recorded responses with the 
light path blocked. In these experiments, we interleaved single synaptic stimulation, flash, paired synaptic stim-
ulation, flash with light path blocked and delivered each one of them every 10 s. Analysis of transporter cur-
rents was performed as described previously28,29,66. All drugs were purchased from Sigma-Aldrich (St. Louis, 
MO), Tocris Bioscience and Hello Bio (Bristol, UK). TFLLR, with C-terminal amidation, was purchased from 
Genscript Biotech Corporation (Piscataway Township, NJ). All experiments were performed at room temperature 
(23–26 °C).
To analyze the facilitated portion of the STCs (fSTCs) and estimate the fast and slow component of the 
decaying phase (τ fast and τ slow, respectively; Supp. Fig. 1, Figs 1 and 2), we fitted the fSTC waveform with the 
multi-exponential equation:
= − + .τ τ τ
− − −
F t A e e A e( ) (1 ) ( ) (1)
t t
n
t t t t
1 2rise fast slow
0 0 0
Two-photon microscopy diffusion analysis. We estimated the diffusion profile of two cell-impermeable 
fluorophores, Alexa Fluor 350 (AF350 0.2 mM; Cat.A10439, Life Technologies, Carlsbad, CA) and Alexa Fluor 
594 (AF594 0.1 mM; Cat.A10438, Life Technologies), with molecular weights (349 and 759 Da, respectively) sim-
ilar to that of glutamate (147 Da) (Savtchenko and Rusakov, 2005; Zheng et al., 2008). The fluorophores were 
loaded into a patch pipette (1.5–2.0 MΩ) connected to a Picospritzer III (Parker Hannifin Precision Fluidics 
Division, Hollis, NH) and pressure applied in free medium (ACSF) or in hippocampal slices (∼ 50 μ m below the 
slice surface). Each pressure application (∼ 13 PSI) lasted for 10 ms. The puff was triggered 200 ms after the begin-
ning of the image acquisition. The two-photon laser scanning system (Scientifica, Uckfield, UK) was powered by 
a Ti:sapphire pulsed laser (Coherent, Bloomfield, CT) tuned to 810 nm and connected to an upright microscope 
with a 60 × 1.0 NA objective (Olympus Corporation). The green and red fluorescent signals were separated by a 
565 nm dichroic mirror and filtered using FITC and TRITC filter sets (Olympus Corporation), respectively. We 
performed line scans (625 Hz) orthogonally to the pipette, at the focal plane of the tip, 5–10 μ m away from it32. 
Ten consecutive line scans (8 s) were collected every 30 s using each pipette. The lines scans were averaged in 
Fiji (http://fiji.sc/Fiji) and analyzed in IgorPro 6.36 (Wavemetrics) with custom-made software (A.S.). We meas-
ured the light intensity profiles every 150 ms, before and after the puff. Each fluorescence profile was fitted with 
Ctrl TFLLR
PSD surface area 0.14 μ m2 0.04 μ m2
Pre-synaptic volume 0.15 μ m3 0.05 μ m3
Post-synaptic volume 0.02 μ m3 0.01 μ m3
Mean astrocytic process volume 0.01 μ m3 0.02 μ m3
Mean astrocytic process SA 0.53 μ m2 0.75 μ m2
Number of astrocytic processes 2 4
PSD- Astrocytic process distance 85 nm 184 nm
Total astrocytic process volume at each 
synapse 0.03 μ m
3 0.07 μ m3
Total astrocytic process SA at each 
synapse 1.07 μ m
2 2.99 μ m2
Table 3. Geometrical properties of reconstructed excitatory synapses used for 3D Monte Carlo reaction-
diffusion simulations (Fig. 5).
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Figure 6. PAR1 activation reduces GluA activation. (A) Left: GluA-EPSC amplitude in control (70.4 ± 15.4 pA) 
and TFLLR (59.1 ± 15.8 pA (n = 21) p = 0.06). Right top: example GluA-EPSCs. Right bottom: TFLLR reduces 
the GluA-EPSC amplitude (0.79 ± 0.07 (n = 21) **p = 0.008). (B) Left: GluA-EPSC PPR in control (1.66 ± 0.10) 
and TFLLR (1.76 ± 0.07 (n = 9) p = 0.39). Right top: example paired GluA-EPSCs. Right bottom: TFLLR does 
not change PPR (1.08 ± 0.06 (n = 9) p = 0.26). (C) As in A, in cyclothiazide (CTZ 100 μ M; Ctrl132.4 ± 30.11 
pA; TFLLR 106.5 ± 32.0 pA (n = 7) p = 0.07). TFLLR reduces the GluA-EPSC amplitude in CTZ (0.78 ± 0.08 
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a Gaussian function (Levenberg-Marquardt algorithm, IgorPro 6.36) and the pre-puff fluorescence profile was 
routinely subtracted from the other recorded diffusion profiles as to avoid any bias from residual fluorescence 
between puffs. The linearity of diffusion of the fluorophores from a point source (the pipette) was verified in a 2 s 
time window after the puff and the diffusion coefficient (Dfree or D*) was estimated from the linear regression of 
γi2/4 versus time, where γ represents the width of the Gaussian profile at time i. For each fluorophore, the tortu-
osity (λ) was estimated as:
λ = D D/ * (2)free
The hydration diameter (dH) was estimated as:
piη=d KT D/3 *, (3)H
where K = Boltzmann’s constant (1.38·10−23 J/K), T = temperature in °K (295°K), η = viscosity of water 
(9.68·10−4 Pa·s) and D* = apparent diffusion coefficient of each fluorophore in control and TFLLR-treated slices.
Electron microscopy and axial STEM tomography. Acute hippocampal slices processed for electron 
microscopy analysis were prepared as described for the electrophysiology experiments. Slices were microwave 
fixed for 13 s in 6% glutaraldehyde, 2% PFA, 2 mM CaCl2 in 0.1 N sodium cacodylate buffer67 and stored over-
night at 4 °C. After 3 washes in 0.1 N cacodylate buffer, we cut samples from the middle part of CA1 stratum 
radiatum, ∼ 100 μ m away from the pyramidal cell layer. These samples were treated with 1% osmium tetroxide 
for 1 hour on ice, en bloc mordanted with 0.25% uranyl acetate at 4 °C overnight, washed and dehydrated with a 
graded series of ethanol, and embedded in epoxy resins. Thin sections (70–90 nm) were counterstained with lead 
citrate and uranyl acetate and examined on a JEOL 1200 EX transmission electron microscope. Images were col-
lected with a CCD digital camera system (XR-100, AMT). To visualize the arrangement of pre-synaptic terminals, 
post-synaptic terminals, and astrocytic processes, thick sections (∼ 1 μ m) were cut from regions of CA1 stratum 
radiatum and electron tomograms were collected in a 300 kV electron microscope operated in the scanning trans-
mission electron microscopy (STEM) mode, as described previously (Hohmann-Marriott et al., 2009; Sousa et al., 
2011). A sample thickness of 1 μ m – enabled by axial STEM tomography68,69 – provides sufficient sample depth 
to visualize features of interest in their entirety, such as synapses. In contrast to standard TEM tomography, con-
ventional TEM tomography is limited to a specimen thickness of ∼ 400 nm and cannot be applied to such thick 
sections because the transmitted electrons undergo multiple inelastic scattering processes, resulting in images 
that are blurred by chromatic aberration of the objective lens. Axial STEM tomography is not affected by chro-
matic aberration because the objective lens that forms the electron probe is in front of the specimen. Recently, 
axial STEM tomography has been applied to image neuronal structures in retina70 and brain71. Dual-axis tilt series 
of selected sections were recorded using an FEI Tecnai TF30 TEM/STEM operating at 300 kV (1.5° tilt incre-
ment, tilt range from 55° to − 55°, pixel size = 1.4 nm). Image registration, tomogram generation, tracing, surface 
area and volume measures were performed using IMOD 4.7 (http://bio3d.colorado.edu/imod/). The tomograms 
did not contain full astrocytes. However, in each tomogram, we identified astrocytic processes based on their 
shape and cytoplasmic structure12. Accordingly, each astrocytic process lacked synaptic vesicles and post-synaptic 
densities and did not give rise to pre- or post-synaptic terminals. The astrocytic processes contained glycogen 
granules, intermediate filament bundles and a clearer cytoplasm with respect to that of neurons. The astrocytic 
processes were traced for the entire thickness of the reconstructed volume (∼ 1 μ m). We reconstructed all the 
nearest neighboring astrocytic processes that separated our synapse of interest from neighboring excitatory syn-
apses. Typically, these astrocyte processes were located < 600 nm away from the selected synapse, which is in 
agreement with available estimates of the mean nearest-neighbor distance between excitatory synapses in CA1 
stratum radiatum (∼ 465 nm)72. We reconstructed a total of 25 synapses (Ctrl: n = 12; TFLLR: n = 13), randomly 
distributed within the axial STEM tomography blocks.
(n = 7) *p = 0.03). (D) AS in B, in CTZ. GluA-EPSC PPR in control (1.90 ± 0.13) and TFLLR (2.08 ± 0.14 
(n = 7) p = 0.19). TFLLR does not change PPR in CTZ (1.10 ± 0.02 (n = 7) p = 0.17). (E) Top: scheme of the 
experimental design. Bottom: time course of GluA-EPSC amplitude. GluA-EPSCs are recorded in control, 
then in kynurenate (300 μ M). Kynurenate was washed out until the GluA-EPSC amplitude recovered to its 
baseline value. Then we applied TFLLR, washed in kynurenate in TFLLR and returned to TFLLR. (F) Left: 
GluA-EPSCs in control (black) and kynurenate (red). Right: same cell, GluA-EPSCs in TFLLR (blue) and in 
TFLLR + kynurenate (red). (G) Summary graph: GluA-EPSCs are blocked more effectively by kynurenate in 
TFLLR (Ctrl 0.29 ± 0.06; TFLLR 0.19 ± 0.02 (n = 7) *p = 0.02). Linear regression (red), 95% confidence bands 
(pink) and Pearson’s correlation coefficient (r) are shown in the graph. (H) Contour plot of the normalized 
GluA-EPSC amplitude in kynurenate (300 μ M). Simulated GluA-EPSC were evoked by glutamate transients 
with different peak concentrations and decay. Thick lines match the kynurenate block observed experimentally, 
in control (green) and TFLLR (yellow). (I) Simulated GluA-EPSC kynurenate-block. (J) Simulated GluA-
EPSC trains evoked by different glutamate transients. (K) Top: GluA-EPSCs in control (black) and TFLLR 
(blue). TFLLR reduced the amplitude of the first GluA-EPSC to 12%. Bottom: GluA-EPSCs normalized by the 
amplitude of the first GluA-EPSC. (L) As in K, for a cell in which TFLLR reduced the amplitude of the first 
GluA-EPSC to 86%. (M) Summary graph: the larger the GluA-EPSC block by TFLLR, the larger is summation 
of consecutive GluA-EPSCs. Linear regression (blue), 95% confidence bands (light blue) and r are shown in the 
graph.
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Figure 7. PAR1 activation reduces GluN activation. (A) Left: GluN-EPSCs in control (black) and TFLLR 
(blue), normalized by the GluN-EPSC peak in control. Right: GluN-EPSC amplitude in control (69.8 ± 19.2 pA)  
and TFLLR (19.8 ± 4.4 pA (n = 8) *p = 0.01). (B) Left: As in A, for GluN-EPSCs in control (black) and after 
30 min recording time (red). Right: GluN-EPSC amp in control (114.4 ± 25.8 pA) and after 30 min (84.7 ± 22.0 
pA (n = 12) *p = 0.03). (C) Left: Peak-normalized GluN-EPSCs in control (black) and TFLLR (blue). Right: 
GluN-EPSC t50 in control (52.6 ± 9.0 ms) and TFLLR (34.2 ± 9.0 ms (n = 8) *p = 0.01). (D) As in C, for time 
dependent control (Ctrl: 61.7 ± 6.2 ms, Time: 56.3 ± 4.9 ms (n = 12) p = 0.20). (E) Left: TFLLR reduces the 
GluN-EPSC amplitude, rise and decay time (Norm GluN-EPSC amp 0.29 ± 0.02 ***p = 1.1e-8, TFLLR vs  
Time ***p = 2.4e-4; Norm GluN-EPSC 20–80% rise 0.71 ± 0.11 *p = 0.04, TFLLR vs Time **p = 7.3e-3; Norm  
GluN-EPSC t50 0.61 ± 0.09 (n = 8) **p = 0.004, TFLLR vs Time *p = 0.01). Right: GluN-EPSC 20–80% rise in 
control (8.1 ± 0.8 ms) and TFLLR (5.6 ± 1.0 ms (n = 8) *p = 0.04). (F) As in E, for time-dependent control. 
Left: (Norm GluN-EPSC amp 0.70 ± 0.08 ***p = 0.003; Norm GluN-EPSC 20–80% rise 1.14 ± 0.08, p = 0.10; 
Norm GluN-EPSC t50 0.971 ± 0.08 (n = 12), p = 0.69). Right: (GluN-EPSC 20–80% rise 4.7 ± 0.6 ms, TFLLR 
5.3 ± 0.7 ms (n = 12) p = 0.11. (G) Left: GluN-EPSCs in control (black) or TFLLR (blue) and after D-AA (100 μ M;  
green). Right: D-AA reduces the GluN-EPSC amplitude more in TFLLR (Norm GluN-EPSC amp Ctrl 0.42 ± 0.05 
***p = 4.5e-7; TFLLR 0.25 ± 0.04 ***p = 2.8e-11; Ctrl vs TFLLR *p = 0.01). (H) Left: GluN-EPSCs in control 
(black) or TFLLR (blue) and after APV (2 μ M; magenta). Right: As in K, for APV (Norm GluN-EPSC amp 
Ctrl 0.30 ± 0.04 ***p = 9.4e-7; TFLLR: 0.36 ± 0.05 ***p = 2.7e-4; Ctrl vs TFLLR p = 0.43). (I) Time course 
of the holding current (Ihold) in control (left) or in TFLLR (right) at a holding potential of 40 mV before and 
after blocking GluN receptors with APV (50 μ M). The pink shaded area represents the duration of the APV 
application. (J) Summary graph: The GluN holding current density, measured as the ratio of the APV-sensitive 
holding current and the cell capacitance, is similar in control (69.8 ± 19.2 pA) and TFLLR (0.28 ± 0.09 pA/pF 
(n = 8) p = 0.53).
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The reconstructed volumes were converted into object files and imported into the open-source software 
Blender 2.76 (https://www.blender.org/). Astrocyte-PSD distance analysis was performed in Blender using 
custom-made analysis software written in Python (M.F.R. and A.S.).
3D Monte Carlo reaction-diffusion simulations. We performed two sets of 3D Monte Carlo 
reaction-diffusion simulations using Blender 2.75 (Windows) or Blender 2.69 (Linux) and the CellBlender 1.0.1 
add-on (http://mcell.org/). The geometrical parameters were based on the ones measured in the axial STEM 
tomography reconstructions of control sections and of sections treated with TFLLR (Table 1). In the first set of 
simulations, we generated simplified geometries of individual synaptic contacts and astrocytic processes (Fig. 4, 
Table 2). Each simulation was run within a 1 μ m3 world. The pre-synaptic terminals (volume Ctrl: 0.079 μ m3, 
TFLLR: 0.065 μ m3; radius Ctrl: 0.27 μ m, TFLLR: 0.24 μ m) and post-synaptic terminals (volume Ctrl: 0.040 μ m3, 
TFLLR: 0.029 μ m3; radius Ctrl: 0.27 μ m, TFLLR: 0.24 μ m) were placed at the center of the world and separated 
from each other by a synaptic cleft of 20 nm height. The control synapse was surrounded by 2 astrocytic processes, 
each with a surface area of 0.69 μ m2 (total astrocyte surface area: 1.38 μ m2). The TFLLR synapse was surrounded 
by 4 astrocytic processes, each with a surface area of 0.54 μ m2 (total astrocyte surface area: 2.18 μ m2). The mean 
distance of the astrocytic processes from the center of the PSD was 116 nm in the control and 190 nm in the 
TFLLR simulation. Each astrocytic process was covered by glutamate transporters (10,800 μ m−2)73. The geometri-
cal parameters for the second set of simulations is included in Table 3. The PSD expressed GluA and GluN recep-
tors (200 and 300 μ m−2, respectively)45,46,74. GluA and GluN receptors were also expressed, at lower density, in the 
extra-synaptic regions (40 and 60 μ m−2, respectively)29,33. The GluN and GluA kinetic rates were set in accordance 
to75 and76, respectively. The glutamate transporters were modeled using the simplified kinetic scheme shown in 
Fig. 4H77. The time constant for glutamate translocation across the membrane was set to ktrans = 2,000s−1 78; the 
transporter reorientation rate was set to kreorient = 50 s−1 77. The scheme included a rapid binding and unbinding 
rates (kon and koff respectively). The binding rate was set to kon = 6e6 M−1 s−1 78. The unbinding rate was derived 
from the equation of the apparent steady state affinity for glutamate:
=
⋅ + ⋅
⋅ ⋅
k
k k k k
k k k( )
,
(4)m
off reorient trans reorient
on trans reorient
in which km = 13 μ M18. The derived value for the unbinding rate was koff = 601. All kinetic rates were adjusted 
for Q10= 3, to approximate the receptor and transporter kinetics at physiological temperature (35 °C). At the 
Figure 8. PAR1 activation impairs LTP. (A) Time course of baseline-normalized fEPSC slope before and 
after LTP induction with a high-frequency stimulation (HFS) protocol (100 Hz, 1 s), in control. (B) As in A, in 
TFLLR. (C) Summary of changes in the EPSC slope induced the by HFS in control (Norm fEPSC slope Ctrl: 
1.31 ± 0.13 (n = 9) *p = 0.04) and TFLLR (0.96 ± 0.09 (n = 6) p = 0.66; Ctrl vs TFLLR *p = 0.04).
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beginning of each simulation, 2,000 glutamate molecules were released from a point source placed in the center 
of the synaptic cleft, close to the pre-synaptic terminal79. In previous work, we showed that the surface density 
of glutamate transporters (10,800 μ m−2) is orders of magnitude larger than the number of glutamate molecules 
released from an individual synaptic contact. Varying the number of released glutamate molecules over a wide 
range from 1,000 to 20,000 in 3D reaction-diffusion simulations similar to those used in the present work did not 
show any appreciable effect on the time course of glutamate clearance from astrocytes (Supp. Fig. 9 in ref. 29). For 
this reason, we released 2,000 glutamate molecules, a number that is in close agreement with currently available 
estimates of the quantal size of glutamatergic synaptic vesicles79. Glutamate diffused within the synaptic cleft with 
a diffusion coefficient D* = 3.3e-6 cm2/s80. The apparent diffusion coefficient was set to 1.41e-6 cm2/s outside of 
the synaptic cleft, to account for the tortuosity of the hippocampal neuropil (λ), which describes the hindrance 
to free diffusion experienced by glutamate as it diffuses in the hippocampal neuropil (λ = 1.6)81. The tortuosity 
factor λ can be described as:
λ λ λ= · , (5)g v
where λg and λv represent the geometrical and viscous components of λ. Previous work estimated λg = 1.48 29 and 
therefore λv = 1.38. In the simulations ran with simplified geometries, only 18% of the simulation volume is occu-
pied by the synaptic elements and astrocytic processes and therefore λ = = .α− 1 04g
3
2
. Therefore, in these 
simulations, the tortuosity is:
λ λ λ λ= ⋅ ⋅ , (6)g v x
where λx is a correction factor to obtain λ= 1.6. In our case, λx = 1.11. The tortuosity can also be expressed as a 
function of the free and apparent diffusion coefficients (Dfree and D*, respectively), accordingly to the formula:
λ = ⁎
D
D
,
(7)
free
from which we obtain:
λ λ
=
·
⁎D
D
( ) (8)
simulation
free
v x
2
(i.e. =⁎Dsimulation 1.41e-6 cm2/s). Each simulation consisted of 5,000 iterations with a time step Δt = 10 μ s (therefore 
spanning a 50 ms time window), and was run for 300 seeds. We averaged the results of all 300 seeds using 
custom-made software written in Python 3.5 (https://www.python.org/). All surfaces for the geometries included 
in the simulation scene were reflective for glutamate. The glutamate concentration and the number of glutamate 
transporter binding, unbinding and translocation reactions were monitored at every time step, in the synaptic 
cleft and in the extracellular space.
Analytical simulations. Analytical simulations of GluA-EPSCs were performed in ChanneLab (Synaptosoft 
Inc., Decatur, GA), with a time interval= 0.01 ms, Vhold= − 70 mV, RK4 integration and step size= 5 μ s (Fig. 6H–J). 
All kinetic rates were taken from42. Data were imported in IgorPro 6.36 to obtain a contour plot (Fig. 6H).
Statistical analysis. Data are presented as mean ± S.E.M, unless otherwise stated. Statistical significance 
was determined by Student’s paired or unpaired t-test, as appropriate (IgorPro 6.36). Differences were considered 
significant at p < 0.05 (*p < 0.05; **p < 0.01; ***p < 0.001).
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